BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8698121)

  • 1. Haemostatic markers of procoagulant imbalance in Behçet's disease.
    Haznedaroğlu IC; Ozcebe O; Celik I; Dündar SV; Kirazhi S
    Eur J Haematol; 1996 Jul; 57(1):107-8. PubMed ID: 8698121
    [No Abstract]   [Full Text] [Related]  

  • 2. [New useful parameters or makers in diagnosis and condition. Analysis of disseminated intravascular coagulation--mainly molecular markers].
    Koike K; Fujimaki M
    Nihon Rinsho; 1993 Jan; 51(1):37-42. PubMed ID: 8433526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy in disseminated intravascular coagulation due to abdominal sepsis: determination of prothrombin fragment 1 + 2 and other markers.
    Okamoto K; Takaki A; Takeda S; Katoh H; Ohsato K
    Haemostasis; 1992; 22(1):17-24. PubMed ID: 1387863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
    Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
    Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
    [No Abstract]   [Full Text] [Related]  

  • 5. [New clinical tests in diagnosis of hematologic diseases].
    Nakahara K
    Nihon Naika Gakkai Zasshi; 1993 Apr; 82(4):529-33. PubMed ID: 8340662
    [No Abstract]   [Full Text] [Related]  

  • 6. TAT and PAP in hemodialysis patients: two cats in a bag?
    Haznedaroğlu IC; Erdem Y; Dündar S; Cağlar S; Kirazh S
    Thromb Res; 1995 Dec; 80(5):447-9. PubMed ID: 8588208
    [No Abstract]   [Full Text] [Related]  

  • 7. [Advancement in the diagnosis of disseminated intravascular coagulation for the surgeon].
    Ohsato K; Okamoto K
    Nihon Rinsho; 1993 Jan; 51(1):50-5. PubMed ID: 8381885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
    Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
    Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
    [No Abstract]   [Full Text] [Related]  

  • 9. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
    Solymoss S; Bovill EG
    Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.
    Hundalani SG; Nguyen KT; Soundar E; Kostousov V; Bomgaars L; Moise A; Hui SK; Teruya J
    Pediatr Crit Care Med; 2014 Jun; 15(5):e198-205. PubMed ID: 24614609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of intravascular coagulation in Bell's palsy.
    Omori H; Ikeda M; Kukimoto N; Kawamoto H; Ikui A; Tomita H
    Eur Arch Otorhinolaryngol; 1994 Dec; ():S471-2. PubMed ID: 10774425
    [No Abstract]   [Full Text] [Related]  

  • 12. Thrombin-antithrombin complex and alpha2-plasmin inhibitor-plasmin complex levels after cesarean section in normal pregnancies and pre-eclampsia.
    Hayashi M; Hamada Y; Ohkura T
    Int J Gynaecol Obstet; 2003 Aug; 82(2):213-6. PubMed ID: 12873784
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombin-antithrombin III and prothrombin fragment 1.2 levels in early respiratory distress syndrome.
    Yurdakök M; Yigit S; Gürakan B; Dündar S; Kirazli S
    Am J Hematol; 1996 Mar; 51(3):247-8. PubMed ID: 8619412
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the activation markers of blood coagulation and fibrinolysis in the neonatal period].
    Ries M; Klinge J; Rauch R; Zenker M; Aydin I; Harms D
    Klin Padiatr; 1996; 208(6):350-4. PubMed ID: 9064377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in coagulation and fibrinolysis cascades upon extracorporeal circulation].
    Kanamori N; Koiwa F; Uda S
    Nihon Rinsho; 1991 Dec; 49 Suppl():81-6. PubMed ID: 1839690
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic abnormalities in patients with thrombotic complications on maintenance hemodialysis.
    Inoue A; Wada H; Takagi M; Yamamuro M; Mukai K; Nakasaki T; Shimura M; Hiyoyama K; Deguchi H; Gabazza EC; Mori Y; Nishikawa M; Deguchi K; Shiku H
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):100-3. PubMed ID: 10775031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemostasis in newborns of smoking and nonsmoking mothers.
    Mercelina-Roumans PE; Ubachs JM; van Wersch JW
    Am J Obstet Gynecol; 1997 Mar; 176(3):662-6. PubMed ID: 9077625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change of lipoprotein(a) and coagulative or fibrinolytic parameters in diabetic patients with nephropathy.
    Nagai T; Tomizawa T; Mori M
    Diabetes Care; 1993 Oct; 16(10):1411-2. PubMed ID: 8269808
    [No Abstract]   [Full Text] [Related]  

  • 19. High F1.2 fragment of prothrombin, thrombin-antithrombin III complex (TAT) and soluble fibrin plasma levels demonstrate hypercoagulability induced during loco-regional thrombolytic therapy with rt-PA.
    Garcia-Avello A; Garcia-Frade LJ; Gandarias C; Ocaña J; Cancelas JA; Lasso M
    Thromb Res; 1994 Jan; 73(2):109-15. PubMed ID: 8171409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravascular hypercoagulability in patients with recent Bell's palsy.
    Omori H; Ikeda M
    Eur Arch Otorhinolaryngol; 1994; 251(5):278-82. PubMed ID: 7986500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.